Lialda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Study of Pentasa ® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
Conditions:   HIV-1-infection;   Gut Inflammation Intervention:   Drug: Pentasa vs Align Sponsors:   AIDS Healthcare Foundation;   HIV Immunotherapeutics Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2018 Category: Research Source Type: clinical trials